![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.295, 2001-01, pp. : 3-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Alosetron and irritable bowel syndrome
By Mayer Emeran A Bradesi Sylvie
Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 11, 2003-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Clinical Drug Investigation, Vol. 27, Iss. 1, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Alosetron in Irritable Bowel Syndrome: Strategies for its Use in a Common Gastrointestinal Disorder
By Lembo A.
Drugs, Vol. 63, Iss. 18, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Diabetes takes its toll in the workplace
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 304, 2001-01 ,pp. :